Fidelity Investments
LENZ

Fidelity Investments’s LENZ Therapeutics LENZ Stock Holding History

Fidelity Investments’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9M Sell
3,597,784
-104,934
-3% -$1.47M ﹤0.01% 1585
2025
Q4 		$59.2M Buy
3,702,718
+3,615,405
+4,141% +$105M ﹤0.01% 1375
2025
Q3 		$4.07M Buy
87,313
+5,674
+7% +$209K ﹤0.01% 2309
2025
Q2 		$2.39M Buy
81,639
+500
+0.6% +$13.6K ﹤0.01% 2430
2025
Q1 		$2.09M Buy
81,139
+80,927
+38,173% +$1.99M ﹤0.01% 2431
2024
Q4 		$6.12K Buy
212
+78
+58% +$2.38K ﹤0.01% 4619
2024
Q3 		$3.18K Buy
134
+37
+38% +$821 ﹤0.01% 4715
2024
Q2 		$1.68K Sell
97
-1,276
-93% -$22.3K ﹤0.01% 4750
2024
Q1 		$30.7K Buy
1,373
+1,223
+815% +$25.4K ﹤0.01% 3818
2023
Q4 		$2.75K Buy
150
+36
+32% +$594 ﹤0.01% 4588
2023
Q3 		$1.99K Sell
114
-71
-38% -$1.24K ﹤0.01% 4540
2023
Q2 		$3.37K Buy
+185
New +$3.7K ﹤0.01% 4471
2023
Q1 		– Sell
-159,446
Closed -$3.71M – 5566
2022
Q4 		$3.71M Sell
159,446
-536,662
-77% -$12.4M ﹤0.01% 2198
2022
Q3 		$15.4M Sell
696,108
-50,672
-7% -$1.21M ﹤0.01% 1700
2022
Q2 		$14.4M Sell
746,780
-287,571
-28% -$6.41M ﹤0.01% 1792
2022
Q1 		$36.9M Buy
1,034,351
+141,824
+16% +$8.87M ﹤0.01% 1521
2021
Q4 		$77.7M Sell
892,527
-274
-0% -$22.7K 0.01% 1225
2021
Q3 		$101M Buy
892,801
+355,375
+66% +$52.6M 0.01% 1105
2021
Q2 		$111M Buy
+537,426
New +$93.6M 0.01% 1082

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments's LENZ Position: Q1 2026 in Review

Fidelity Investments reduced its LENZ Therapeutics (LENZ) stake by 2.8% in Q1 2026, selling an estimated $1.47M and leaving 3,597,784 shares worth $32.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Fidelity Investments first reported a position in LENZ in Q2 2021 and has held it in 19 quarters since. The position peaked at $111M in Q2 2021. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Fidelity Investments held 3,597,784 shares of LENZ Therapeutics worth $32.9M as of Q1 2026.
  • Fidelity Investments sold 104,934 LENZ Therapeutics shares in Q1 2026, an estimated $1.47M.
  • LENZ Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1585 holding.
  • Fidelity Investments first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Fidelity Investments's LENZ Therapeutics position peaked at $111M in Q2 2021.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.